R. Schlienger

First name

R.

Middle name

G.

Last name

Schlienger

Fischer, L. M., Schlienger, R. G., Matter, C., Jick, H., & Meier, C. R. (2004). Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol.

View

Fischer, L. M., Schlienger, R. G., Matter, C. M., Jick, H., & Meier, C. R. (2005). Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction. Pharmacotherapy.

View

Schlienger, R. G., Fedson, D. S., Jick, S. S., Jick, H., & Meier, C. R. (2007). Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy. http://doi.org/10.1592/phco.27.3.325

View

Bruderer, S. G., Bodmer, M., Jick, S. S., Bader, G., Schlienger, R. G., & Meier, C. R. (2014). Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK\textendasha nested case-control analysis. Diabetes Obes Metab. http://doi.org/10.1111/dom.12282

View

Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., et al. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z

View

Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., et al. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825

View